NEW YORK (GenomeWeb News) – Akesogen today announced the US Department of Veterans Affairs has awarded the company a five-year, $7.5 million contract to genotype samples from US military veterans as part of the Million Veteran Program.

In the first year of the contract, Akesogen, a genomics and biorepository firm based in Norcross, Ga., will use a custom designed array-based genotyping product from Affymetrix to genotype 105,000 veterans, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.